“The future of environmental, social and governance will be shaped by innovation and sustainable solutions,” Dzeneta Mulabegovic, strategic specialist, UNDP, Việt Nam, said.
The main challenges associated with existing lung cancer drugs are severe side effects and drug resistance. There is hence a constant need to explore new molecules for improving the survival rate and quality of life of lung cancer patients.